RedHill Biopharma (RDHL) Operating Leases (2019 - 2025)
RedHill Biopharma (RDHL) posted quarterly Operating Leases of $900000.0 for Q4 2025, up 29900.0% year-over-year from N/an in Q4 2024, and up 29900.0% quarter-over-quarter from $3000.0 in Q4 2024.
RedHill Biopharma (RDHL) Operating Leases (2019 - 2025) Analysis & Trends
RedHill Biopharma (RDHL) has reported Operating Leases for 7 consecutive years, with $900000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Operating Leases rose 29900.0% year-over-year to $900000.0; the TTM figure through Dec 2025 stood at $900000.0 (up 29900.0% YoY), while the FY2025 annual figure was $900000.0, up 29900.0% from the prior year.
- Operating Leases climbed to $900000.0 in Q4 2025 per RDHL's latest filing, from $3000.0 in the prior quarter.
- Across five years, Operating Leases topped out at $6.7 million in Q2 2022 and bottomed at $3000.0 in Q4 2024.
- Historically, Operating Leases has averaged $2.6 million across 5 years, with a median of $1.8 million in 2021.
- Annual changes were most pronounced in 2024 — Operating Leases slumped 99.34% — and 2025, when it surged 29900.0%.
- RedHill Biopharma's Operating Leases stood at $2.6 million in 2021, then surged by 150.31% to $6.4 million in 2022, then tumbled by 92.94% to $455000.0 in 2023, then plunged by 99.34% to $3000.0 in 2024, then soared by 29900.0% to $900000.0 in 2025.
- Business Quant data shows RDHL's Operating Leases at $900000.0 in Q4 2025, $3000.0 in Q4 2024, and $190000.0 in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 900,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Jun 30, 2024 | 190,000.00 |
| Dec 31, 2023 | 455,000.00 |
| Jun 30, 2023 | 994,000.00 |
| Dec 31, 2022 | 6.44 Mn |
| Jun 30, 2022 | 6.67 Mn |
| Mar 31, 2022 | 4.80 Mn |
| Dec 31, 2021 | 2.57 Mn |
| Jun 30, 2021 | 2.98 Mn |
| Dec 31, 2020 | 3.81 Mn |
| Jun 30, 2020 | 4.04 Mn |
| Dec 31, 2019 | 2.98 Mn |
| Jun 30, 2019 | 3.23 Mn |